Table II. The sceening of monoclonal antibodies.
| Clonal number | Immunohistochemical assay |
CCK-8 assay inhibatory rate | Subtype |
||
|---|---|---|---|---|---|
| lung cancer | lung | heavy chain | light chain | ||
| 5B8 | 69.5% (73/105) | 4.7% (5/105) | 15% | IgM | k |
| 5D4 | 78% (82/105) | 2.9% (3/105) | 19% | IgG1 | k |
| 4D10 | 80% (84/105) | 2.9% (3/105) | 20% | IgG1 | k |
| 2B4 | 85.7% (90/105) | 8.6% (9/105) | 21% | IgM | k |
| 2F9 | 92.4% (97/105) | 7.6% (8/105) | 25% | IgM | k |
| 13H3 | 98.1 (103/105) | 1.9% (2/105) | 29% | IgM | k |